The survival time of gastrointestinal mesenchymal stromal tumors is not generalized, the general “5-year survival rate” is 55-93%, and the specific survival time is related to the risk classification, the type of pathology, the method of treatment, and whether there is a recurrence after the treatment, etc. The earlier the disease is detected, the earlier it is diagnosed, the earlier it is treated, the more impact the disease has on life. In general, the earlier the disease is detected, diagnosed and treated, the less impact it has on life expectancy. Statistically, the 5-year survival rates for limited, locally progressive and metastatic gastrointestinal mesenchymal tumors are approximately 93%, 80% and 55%, respectively. Those with a low risk hazard are benign and have no significant impact on patient survival time. In the medium, high risk hazard, complete surgical resection is currently the only method of eradication, while the median survival of patients who cannot be surgically resected or who have been extensively metastasized is only 9 to 20 months. It should be noted that patients with gastrointestinal mesenchymal stromal tumors can improve their prognosis and reduce the adverse effects of the disease through “early detection, early diagnosis, early treatment”, and it is recommended that patients actively undergo regular treatment.